(ThePennyWatcher.com) – Science fiction fans dreamed of one day controlling technology with our minds. Now Elon Musk’s company Neuralink is making this dream a reality with their brain to computer interface that is fully implantable and cosmetically undetectable!
This innovation allows us to control devices using only our thoughts, opening up an entirely new world of opportunity for those living with disabilities as well as those looking to enhance their cognitive abilities.
This is where we are folks. Let’s delve deeper into what this all means.
Neuralink’s History & Progress
Neuralink, founded by Elon Musk in 2016 as a neurotechnology company dedicated to brain-machine interface technology development, began their quest with their latest advancements of an implantable brain to computer interface system. Now they’re closer than ever before in making this dream a reality!
Their latest creation, the “Link,” is a small device intended for direct implantation into the brain that acts as an interface between it and a computer. The “Link” has been developed as minimally invasive as possible with no wires visible once implanted, leaving only a tiny scar visible upon scalp inspection as evidence of presence of implant.
Imagine having control of smartphones, cars, or robotic prosthetics simply with their mind! It provides people with disabilities greater independence than ever before.
Neuralink has successfully tested this technology on rats, allowing them to control computer cursors with their minds! So the technology may offer much more than disability relief alone.
Neurotechnology Will Fuel Human Progress
Neuralink’s advances in neurotechnology will usher in a new era of human progress. Not only will its innovative tools offer extraordinary cognitive improvements for users, but also allow those living with disabilities greater independence by giving them new ways to interact with the world. It may even contribute to creating super humans with unparalleled computational and cognitive abilities!
And recently, regulatory approval was given for its first clinical trial using humans. How amazing is that.
We are here!
